Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-065800
Filing Date
2025-05-07
Accepted
2025-05-07 16:40:22
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q krro-20250331.htm   iXBRL 10-Q 2126261
2 EX-10.1 krro-ex10_1.htm EX-10.1 171722
3 EX-31.1 krro-ex31_1.htm EX-31.1 19144
4 EX-31.2 krro-ex31_2.htm EX-31.2 19014
5 EX-32.1 krro-ex32_1.htm EX-32.1 11165
  Complete submission text file 0000950170-25-065800.txt   8736724

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT krro-20250331.xsd EX-101.SCH 1439754
79 EXTRACTED XBRL INSTANCE DOCUMENT krro-20250331_htm.xml XML 1301039
Mailing Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141
Business Address 60 FIRST STREET 2ND FLOOR, SUITE 250 CAMBRIDGE MA 02141 617-468-1999
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

EIN.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39062 | Film No.: 25922116
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)